Pre-eclampsia is a complication of pregnancy that has a relatively high frequency. Most women affected by this disorder do not have severe symptoms, but those who develop eclampsia may be affected, both the pregnant and the fetus. The consequences in severe cases may range from placental abruption, premature labour, organic failure, seizures, etc. Preeclampsia may develop in the early stages of pregnancy (early preeclampsia), making it necessary to induce labour before the 34th week of gestation or late pregnancy (late preeclampsia). Current screening for preeclampsia includes ultrasound parameters and early detection of its symptoms (from the 25th week or 34th, more frequent). However, if detected in the first trimester of pregnancy, allows appropriate monitoring of the pregnant and the fetus.
The test analyses the sFlt-1 / PlGF ratio through the chemiluminescence technique.
This test is indicated for women with suspected preenclampsia, from mid-gestation.
• Guaranteed from the experience of the Synlab group, the absolute European leader in laboratory diagnosis.
• Objective and detailed results report.
DOCUMENTATION – Available on Extranet for clients:
• Informed Consent.
• Clinical Questionnaire.
• Fasting is not necessary for the test.